Page results
-
Information about sickle cell disorder in adulthood for UCLH patients.
-
This page is about the leukaemia multidisciplinary team (MDT) and how they can help you through your treatment.
-
This page is for parents and carers of children with sickle cell disease. It explains what happens during a Transcranial Doppler Scan.
-
This is an easy read page for patients with deep vein thrombosis (DVT).
-
Join in our reflective heart Christmas 2020 campaign! Every year, supporters, staff and friends of UCLH Charity write a message of thanks, celebration or remembrance on a reflective heart together with a donation.
-
Information about incentive spirometry (IS) for adults with sickle cell disorder.
-
Support patients in hospital this Christmas and the staff looking after them by donating to our UCLH Charity Gift of Giving Appeal.
-
Many of our consultants in infectious and tropical diseases hold the only dedicated NHS positions in their respective fields, including parasitology, leprosy, leishmaniasis, and tropical dermatology.
-
The Royal National Ear Nose and Throat Hospital is a national and international centre for voice disorders. The voice service includes four consultant laryngologists, eight speech and language therapists and specialist nurses.
-
I would like to make a payment to UCLH, I have a query about reclaiming expenses for treatment or transport at University College Hospital or I have a query about expenses for treatment or transport at Queen Square (NHNN/RLHIM)
File results
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab